Merck’s HIV drug Idvynso might develop into a drug alternative for sufferers who want to modify from Gilead Sciences’ Biktarvy for security or tolerability causes. The Merck mixture drug pairs two molecules that carry completely different mechanisms of motion to suppressing HIV.
The publish FDA Nod for Merck HIV Drug Brings Competitors to a Gilead Sciences Antiretroviral appeared first on MedCity Information.
